Dupilumab in Elderly Patients With Severe Atopic DermatitisFilomena Russo, Maria Laura Flori, Nicola Milanesi et al.|Dermatitis|2020Cited by 20
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective StudyMarco Galluzzo, Pietro Rubegni, Andrea Chiricozzi et al.|Journal of Clinical Medicine|2024Cited by 7
Dupilumab and Atopic Dermatitis Flares: An Observational Study to Identify Common Clinical Features in Patients Who Have Exacerbations despite Biological TherapyFilomena Russo, Francesco Santi, Vittoria Cioppa et al.|Dermatitis|2023Cited by 3
Autoimmune polyglandular type IIIc syndrome associated with Vogt-Koyanagi-Harada syndrome and common variable immunodeficiency.Roberta Colucci, Silvia Moretti, Massimiliano Galeone et al.|PubMed|2015Cited by 2
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world studyFrancesca Barei, Maddalena Napolitano, Stefano Macchi et al.|Clinical and Experimental Dermatology|2025Cited by 2